Cantor Fitzgerald Pacific Biosciences Prices $86.9M Public Stock Offering The sequencing firm is offering 19.4 million shares of common stock at $4.47 per share and plans to use the proceeds for product launches, among other uses. HTG Molecular Diagnostics Files for $20M Stock Offering The Tucson, Arizona-based company previously raised $20 million through a public offering of its shares and a purchase deal with certain investors. Cantor Fitzgerald Downgrades PerkinElmer to Neutral The investment bank, which maintained its $60 price target for the company's stock, said it is looking for signs of revenue acceleration. Cantor Fitzgerald Initiates Coverage on Rosetta Genomics, Veracyte The investment bank initiated coverage on Rosetta Genomics and Veracyte, rating the molecular diagnostic firms' shares speculative buy and buy, respectively. Cancer Genetics, Cantor Fitzgerald Reach $20M Stock Sales Agreement The company also said that its cash burn rate for Q2 is estimated to be about $4.8 million, or $1.3 million more than its average cash burn. Feb 4, 2015 PacBio, Cantor Fitzgerald Amend Deal to Offer up to $30M in Stock Breaking News 23andMe Fiscal Q4 Revenues Increase 14 Percent Local Coverage Determinations Roundup: Castle Bio, SkylineDx Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood Test Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test The Scan Billion-Dollar Diversity Initiative The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce. Biotech Co-Founder Arrested A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News. Return of the Tasmanian Tiger The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction. Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.